Executive Director, Payer Strategy and Engagement (Tumor HI Program)

Rezolute•Redwood City, CA

3d•$290,000 - $320,000•Hybrid

About The Position

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. This role provides critical leadership and above-country market access strategies including core disease models, value stories, global pricing, economic modeling, and input into Clinical Development programs. The position involves working closely with Medical Affairs colleagues, Organized customers and Distribution providers to identify real-world and patient quality of life data capture / evidence value solutions and publication opportunities. The role also monitors healthcare legislative trends, understands healthcare policies, assesses implications of policies, and develops reimbursement strategies that address barriers to provider and patient access. Understanding total cost of care and all aspects of reimbursement (coverage, coding, and payment) for outpatient and inpatient settings across multiple payer segments is crucial. The role supports the formulation of a clear and compelling disease and product value propositions through the creation of payer engagement (AMCP Dossier, Value and Economic Prop.), and provider / patient reimbursement support tools. It also involves monitoring the competition to understand how the evolving market will impact current and future market access strategies. The position identifies and develops pricing recommendations, coding and reimbursement strategies for current and pipeline assets that will support future Pricing and Reimbursement decisions in the US and other key Ex-US markets. Engagement to support the advancement of ICD-10 CM coding initiatives, and product-specific HCPCS coding application is also a key responsibility. The role identifies product market access risks and opportunities, incorporates them into pipeline product strategies and reflects them in identified Target Product Profiles. It also identifies pricing and reimbursement analogues to support value and access decisions, and creates payer materials for branded and unbranded disease awareness campaigns. Support the identification, creation of defensible, performance driven, quality / outcomes or risked based product / portfolio contract, or rebate opportunities. The role manages agency relationships and contracts to deliver tools/tactics/resources, and ensures on time delivery, that is aligned with the departmental budget. It provides subject matter expertise to the broader organization, including competitive and product coverage access intelligence, healthcare reform, landscape trends, and pull-through initiatives. This includes cross-functional support of corp. training initiatives, content, tools and presentation development in partnership with Training and Cross-Departmental leaders. The role represents Rezolute at Key Industry Conferences (e.g. AMCP, PCMA, ISPOR, Asembia, etc.). Ensuring that all activities and interactions are carried out with the highest ethical and professional standards, and that all work is accomplished with quality and in accordance with Rezolute values is paramount.

Requirements

Experience with rare/orphan drugs is required.
Product launch experience is required.
Familiarity with current legal and regulatory landscape pertinent to the pharmaceutical/biotechnology industry.
Strong analytical capabilities, with working knowledge of government pricing practices (calculations methodologies, HTA, healthcare programs, and supporting regulations), and trade systems and processes.
Demonstrated flexibility to adapt to a changing environment, implement creative solutions to complex problems, and ability to function in a project leadership role.
Ability to develop and maintain strong internal and external relationships, including direct collaboration with vendors and other third parties.
Superior interpersonal, oral and written communication, and presentation skills, with great attention to detail.
Leads with strong business acumen and a compliance mindset.
Passionate about patients and building a new commercial organization.
Advanced Microsoft Excel, Word and PowerPoint skills.

Nice To Haves

Therapeutic area experience is a plus.
Company start-up experience is preferred.
Advanced degree related medical, health economics, health outcomes research, or epidemiology (MS, MBA, MPH, MD/DO, PhD, PharmD) preferred.
Global and/or international experience preferred.

Responsibilities

Provide critical leadership and above-country market access strategies including core disease models, value stories, global pricing, economic modeling, and input into Clinical Development programs.
Work closely with Medical Affairs colleagues, Organized customers and Distribution providers to identify real-world and patient quality of life data capture / evidence value solutions and publication opportunities.
Monitors healthcare legislative trends, understands healthcare policies, assesses implications of policies, and develops reimbursement strategies that address barriers to provider and patient access.
Understands total cost of care and all aspects of reimbursement (coverage, coding, and payment) for outpatient and inpatient settings across multiple payer segments.
Support the formulation of a clear and compelling disease and product value propositions through the creation of payer engagement (AMCP Dossier, Value and Economic Prop.), and provider / patient reimbursement support tools.
Monitor the competition to understand how the evolving market will impact current and future market access strategies.
Identify and develop pricing recommendations, coding and reimbursement strategies for current and pipeline assets that will support future Pricing and Reimbursement decisions in the US and other key Ex-US markets.
Engage to support the advancement of ICD-10 CM coding initiatives, and product-specific HCPCS coding application.
Identify product market access risks and opportunities, incorporate them into pipeline product strategies and reflect them in identified Target Product Profiles.
Identify pricing and reimbursement analogues to support value and access decisions.
Create payer materials for branded and unbranded disease awareness campaigns.
Support the identification, creation of defensible, performance driven, quality / outcomes or risked based product / portfolio contract, or rebate opportunities.
Manage agency relationships and contracts to deliver tools/tactics/resources, and ensure on time delivery, that is aligned with the departmental budget.
Provide subject matter expertise to the broader organization, including competitive and product coverage access intelligence, healthcare reform, landscape trends, and pull-through initiatives. This includes cross-functional support of corp. training initiatives, content, tools and presentation development in partnership with Training and Cross-Departmental leaders.
Represent Rezolute at Key Industry Conferences (e.g. AMCP, PCMA, ISPOR, Asembia, etc.).
Ensure that all activities and interactions are carried out with the highest ethical and professional standards, and that all work is accomplished with quality and in accordance with Rezolute values.